Koers Windtree Therapeutics Inc Nasdaq
Aandelen
US97382D1054
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 2,52 mln. 2,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -21 mln. -19,52 mln. | Nettowinst (verlies) 2025 * | -29 mln. -26,95 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,28
x | K/w-verhouding 2025 * |
-0,42
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,34% |
Recentste transcriptie over Windtree Therapeutics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01-02-16 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09-03-20 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03-02-21 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22-06-23 |
Leslie Williams
BRD | Director/Board Member | 64 | 03-02-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |